BIOL

Biolase, Inc.
BIOL

Overview Fund Activity
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

44 hedge funds and large institutions have $48.1M invested in Biolase, Inc. in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 11 closing their positions.

Holders
44
Holders Change
-6
Holders Change %
-12%
% of All Funds
1.19%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
12
Reduced
13
Closed
11
Calls
$82K
Puts
–
Net Calls
+$82K
Net Calls Change
+$82K

Top Buyers

1
Boston Partners
1
Boston Partners
Massachusetts
$2.49M
2
CCM
2
Consonance Capital Management
New York
$1.16M
3
VAM
3
Visium Asset Management
New York
$3.07M
4
Stifel Financial
4
Stifel Financial
Missouri
$147K
5
QSS
5
Quantitative Systematic Strategies
Florida
$105K

Top Sellers

1
CCM
1
Camber Capital Management
Massachusetts
$9.28M
2
ACA
2
Avoro Capital Advisors
New York
$0
3
RA
3
Royce & Associates
New York
$0
4
VKH
4
Virtu KCG Holdings
New York
$0
5
SM
5
Sabby Management
Florida
$522K
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$0 161 -1,849 -92%
Creative Planning
52
Creative Planning
Kansas
– – -671 Closed
GC
53
Globeflex Capital
California
– – -239 Closed
Citigroup
54
Citigroup
New York
– – -37 Closed
IWM
55
Integrated Wealth Management
California
$0 215 – –
1 2
3